Rating Change
Mizuho analysts initiated coverage on REGENXBIO Inc. (NASDAQ:RGNX) with a rating of Outperform on October 05, 2026.
new coverageNASDAQ:RGNX
Mizuho Initiates Coverage on REGENXBIO Inc. (RGNX) with Outperform
Mizuho analysts initiated coverage on REGENXBIO Inc. (NASDAQ:RGNX) with a rating of Outperform on October 05, 2026.
At publication ·
What changed
REGENXBIO Inc. (NASDAQ:RGNX) · new coverage
- Firm
- Mizuho
- Rating
- Outperform
- Price at event
- $7.79
- Market capitalization
- $651.0M
At a glance
Key takeaways
- Mizuho initiated coverage of REGENXBIO Inc. (RGNX) with an Outperform rating on October 5, 2026, as the stock trades at $7.79 with a market capitalization of $651.0 million.
Market Context
REGENXBIO Inc. operates in the Healthcare sector. The stock currently trades at $7.79 with a market capitalization of $651.0M.
Analyst coverage from Mizuho provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for REGENXBIO Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for REGENXBIO Inc.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 05, 2026 | Mizuho | Outperform | N/A |
| Aug 25, 2026 | Baird | Outperform | N/A |
| Aug 25, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 10, 2026 | HC Wainwright & Co. | Buy | N/A |
| Aug 07, 2026 | Barclays | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View RGNX Stock Page
Frequently Asked Questions
What does the Outperform rating mean for RGNX?
A rating of Outperform from Mizuho reflects the analyst's outlook on REGENXBIO Inc. (NASDAQ:RGNX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the RGNX forecast page.